LONDON — AstraZeneca said Thursday that it intends to seek U.S. authorization for its Covid-19 vaccine in the second half of this year, offering a new timetable for the much-delayed application.
Despite complaints from the E.U. about its vaccine supply, the 27-nation bloc received more doses directly from AstraZeneca than any other single entity in the first half of the year. The company shipped 97 million doses to the E.U., while Brazil got 65 million and the U.K. 52 million,
Authorization from who?
They've really helped Australia a clot. They've helped a clot of us get vaccinated.
LOL pass
The lethal vaccine.
Pfizer bitch here. I could never 💅🏻💅🏻💅🏻
Might want to watch this before you have a vaccine ..
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Health Trusts cancel surgeries as Covid admissions riseThe chief medical officer says the health service is operating under 'huge pressures'. JanePod4
Source: bbchealth - 🏆 143. / 63 Read more »
AstraZeneca says Covid-19 vaccine showed no increased incidence of rare blood clots after second doseThe estimated rate of thrombosis with thrombocytopenia syndrome was 2.3 for every million vaccines, with incidence rates comparable to those among... Strong sell JohnsonJohnson Astrazenaca thanks Of course not. If one give you clots then more would not give you mow clotting.
Source: MarketWatch - 🏆 3. / 97 Read more »
‘Not clear yet’ if booster shots of Covid vaccine are needed, AstraZeneca CEO saysSpeaking to CNBC, AstraZeneca's CEO said the company did not have a 'precise answer' on whether a third dose of its Covid-19 vaccine would be needed. this is terrible news Who cares...sheeps wont ask questions, they will get it ...
Source: CNBC - 🏆 12. / 72 Read more »
AstraZeneca Loses Money on Covid-19 Vaccine for Second Straight QuarterThe British-Swedish drugmaker narrowed losses from its Covid-19 vaccine in the second quarter, but the shot continued to weigh on the drug giant’s earnings. Such a contrast to their competition! You are serving the humanity. So why you guys are worrying about money..? All this is for Nobel cause. Isn't it..?
Source: WSJ - 🏆 98. / 63 Read more »
AstraZeneca Eyes Full U.S. Approval For Covid Shot This Year, Skipping Faster Emergency AuthorizationI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com Strong sell
Source: Forbes - 🏆 394. / 53 Read more »
Pfizer Raises Full-Year Outlook on Covid-19 Vaccine SalesThe pharmaceutical company’s Covid-19 vaccine co-developed with BioNTech contributed $7.8 billion to Pfizer’s total sales of $18.98 billion in the latest quarter. Shocking...and people think it's not all about the dollar. 😂🤦♂️😳 Well people are awake now, they'll fail badly now Go get your free shot, y'all
Source: WSJ - 🏆 98. / 63 Read more »